Geode Capital Management’s Clearside Biomedical CLSD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $632K | Sell |
790,373
-1,874
| -0.2% | -$1.5K | ﹤0.01% | 3477 |
|
2025
Q1 | $727K | Buy |
792,247
+28,189
| +4% | +$25.9K | ﹤0.01% | 3411 |
|
2024
Q4 | $726K | Buy |
764,058
+32,672
| +4% | +$31K | ﹤0.01% | 3482 |
|
2024
Q3 | $929K | Buy |
731,386
+59,089
| +9% | +$75.1K | ﹤0.01% | 3379 |
|
2024
Q2 | $874K | Buy |
672,297
+30,084
| +5% | +$39.1K | ﹤0.01% | 3356 |
|
2024
Q1 | $983K | Buy |
642,213
+151,523
| +31% | +$232K | ﹤0.01% | 3363 |
|
2023
Q4 | $574K | Hold |
490,690
| – | – | ﹤0.01% | 3556 |
|
2023
Q3 | $427K | Sell |
490,690
-8,517
| -2% | -$7.41K | ﹤0.01% | 3663 |
|
2023
Q2 | $559K | Sell |
499,207
-30,890
| -6% | -$34.6K | ﹤0.01% | 3598 |
|
2023
Q1 | $551K | Hold |
530,097
| – | – | ﹤0.01% | 3606 |
|
2022
Q4 | $593K | Buy |
530,097
+4,790
| +0.9% | +$5.36K | ﹤0.01% | 3585 |
|
2022
Q3 | $593K | Buy |
525,307
+1,316
| +0.3% | +$1.49K | ﹤0.01% | 3636 |
|
2022
Q2 | $770K | Buy |
523,991
+34,062
| +7% | +$50.1K | ﹤0.01% | 3537 |
|
2022
Q1 | $1.12M | Buy |
489,929
+3,287
| +0.7% | +$7.52K | ﹤0.01% | 3566 |
|
2021
Q4 | $1.34M | Hold |
486,642
| – | – | ﹤0.01% | 3567 |
|
2021
Q3 | $2.92M | Buy |
486,642
+63,101
| +15% | +$378K | ﹤0.01% | 3195 |
|
2021
Q2 | $2.06M | Buy |
423,541
+58,818
| +16% | +$286K | ﹤0.01% | 3261 |
|
2021
Q1 | $900K | Buy |
364,723
+38,528
| +12% | +$95.1K | ﹤0.01% | 3598 |
|
2020
Q4 | $893K | Hold |
326,195
| – | – | ﹤0.01% | 3398 |
|
2020
Q3 | $502K | Hold |
326,195
| – | – | ﹤0.01% | 3429 |
|
2020
Q2 | $613K | Hold |
326,195
| – | – | ﹤0.01% | 3300 |
|
2020
Q1 | $554K | Buy |
326,195
+50,160
| +18% | +$85.2K | ﹤0.01% | 3247 |
|
2019
Q4 | $800K | Buy |
276,035
+30,856
| +13% | +$89.4K | ﹤0.01% | 3353 |
|
2019
Q3 | $154K | Sell |
245,179
-809
| -0.3% | -$508 | ﹤0.01% | 3854 |
|
2019
Q2 | $239K | Sell |
245,988
-73,602
| -23% | -$71.5K | ﹤0.01% | 3740 |
|
2019
Q1 | $441K | Buy |
319,590
+16,078
| +5% | +$22.2K | ﹤0.01% | 3480 |
|
2018
Q4 | $324K | Buy |
303,512
+14,181
| +5% | +$15.1K | ﹤0.01% | 3526 |
|
2018
Q3 | $1.78M | Buy |
289,331
+14,290
| +5% | +$87.9K | ﹤0.01% | 2951 |
|
2018
Q2 | $2.94M | Buy |
275,041
+32,202
| +13% | +$344K | ﹤0.01% | 2624 |
|
2018
Q1 | $2.61M | Buy |
242,839
+112,992
| +87% | +$1.21M | ﹤0.01% | 2623 |
|
2017
Q4 | $908K | Buy |
129,847
+3,761
| +3% | +$26.3K | ﹤0.01% | 3139 |
|
2017
Q3 | $1.1M | Buy |
126,086
+3,001
| +2% | +$26.2K | ﹤0.01% | 3080 |
|
2017
Q2 | $1.12M | Buy |
123,085
+26,761
| +28% | +$244K | ﹤0.01% | 3056 |
|
2017
Q1 | $764K | Buy |
96,324
+5,596
| +6% | +$44.4K | ﹤0.01% | 3140 |
|
2016
Q4 | $811K | Buy |
90,728
+48,653
| +116% | +$435K | ﹤0.01% | 3092 |
|
2016
Q3 | $730K | Buy |
+42,075
| New | +$730K | ﹤0.01% | 3097 |
|